NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 54 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -87.8% | 30,433 | -86.6% | 0.00% | – |
| Q1 2020 | $131,000 | -90.8% | 227,565 | -78.9% | 0.00% | -100.0% |
| Q4 2019 | $1,425,000 | -48.4% | 1,079,665 | -21.7% | 0.00% | -50.0% |
| Q3 2019 | $2,759,000 | -12.6% | 1,379,265 | +6.1% | 0.00% | -33.3% |
| Q2 2019 | $3,157,000 | +51.2% | 1,299,365 | +51.8% | 0.00% | +50.0% |
| Q1 2019 | $2,088,000 | +169.8% | 855,765 | +61.4% | 0.00% | +100.0% |
| Q4 2018 | $774,000 | +0.5% | 530,165 | +85.8% | 0.00% | 0.0% |
| Q3 2018 | $770,000 | +299.0% | 285,300 | +576.1% | 0.00% | – |
| Q2 2018 | $193,000 | +30.4% | 42,200 | +43.5% | 0.00% | – |
| Q1 2018 | $148,000 | -86.4% | 29,400 | -83.9% | 0.00% | -100.0% |
| Q4 2017 | $1,091,000 | – | 182,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |